4th Quarter - Report

THE NICKLES GROUP, LLC for BAXALTA INC.

Firm
Client
Income
$28,750
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 6, The 21st Century Cures Act and the Innovations Initiative. Issues concerning care for chronic disease patients.

LobbyistCovered position, as disclosed
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Taxation/Internal Revenue Code TAX

Issues related to corporate tax reform and the taxation of U.S. multinational corporations. S. 149, the Medical Device Access and Innovation Protection Act and H.R. 160, the Protect Medical Innovation Act, and issues related to repeal of the medical device tax. S. 1946, the Tax Relief Extension Act of 2015; H.R. 34, the Tax Increase Prevention and Real Estate Investment Act of 2015; H.R. 2029, Consolidated Appropriations Act, 2016, as they relate to the R&D credit, bonus depreciation, the CFC look-through rule and the medical device tax. Issues related to corporate mergers.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2029 (114th), S. 1946 (114th), S. 149 (114th), H.R. 34 (114th), H.R. 160 (114th)

Medicare/Medicaid MMM

H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors; S. 275 / H.R. 605, the Medicare Home Infusion Site of Care Act of 2015 and issues related to reimbursement for infused drugs administered through DME.

LobbyistCovered position, as disclosed
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 275 (114th), H.R. 2570 (114th), H.R. 605 (114th)

Budget/Appropriations BUD

H.R. 3762, Restoring Americans' Healthcare Freedom Reconciliation Act of 2015, as it relates to the repeal of the medical device tax. H.R. 2029, Consolidated Appropriations Act, 2016, as it relates to the delay repeal of the medical device tax and reimbursement for infused drugs administered through DME. H.R. 1314, Bipartisan Budget Act of 2015.

LobbyistCovered position, as disclosed
RACHEL JONES HENSLER —
EMILY PORTER —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3762 (114th), H.R. 2029 (114th), H.R. 1314 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.